Ciro De Luca

Papers

Total Citations

H-Index

About

Ciro De Luca is a urologic surgeon and researcher whose work centers on optimizing surgical outcomes in prostate cancer care, with a particular focus on robot-assisted radical prostatectomy (RARP). His key research areas include perioperative hematologic changes, blood loss management, and the recovery trajectories of patients undergoing minimally invasive prostate surgery. De Luca’s major contribution lies in systematically characterizing the red cell line trends following RARP, providing clinicians with evidence-based benchmarks to anticipate and manage postoperative anemia. His most-cited study, a 2022 analysis of 453 consecutive patients, demonstrated that while hemoglobin and hematocrit levels decline predictably after RARP, the majority of patients maintain stable values without requiring transfusion—a finding that reinforces the safety profile of the robotic approach. With 5 citations to date, this work has informed perioperative protocols and helped reduce unnecessary interventions. De Luca’s research bridges the gap between surgical technique and patient physiology, offering practical guidance for urologists seeking to minimize complications and enhance recovery. His ongoing efforts continue to shape best practices in robotic urologic oncology.